| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0029 | 1 |